These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38538559)

  • 21. Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy-Results of a Prospective Single-Center Trial.
    Benning L; Morath C; Fink A; Rudek M; Speer C; Kälble F; Nusshag C; Beimler J; Schwab C; Waldherr R; Zeier M; Süsal C; Tran TH
    Transpl Int; 2023; 36():11899. PubMed ID: 38020751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation.
    Ventura-Aguiar P; Ramirez-Bajo MJ; Rovira J; Bañón-Maneus E; Hierro N; Lazo M; Cuatrecasas M; Garcia-Criado MA; Liang N; Swenerton RK; Cofan F; Cucchiari D; Esforzado N; Montagud-Marrahi E; Oppenheimer F; Piñeiro G; Revuelta I; Torregrosa V; Ahmed E; Soboleva K; Kaur N; Zimmermann BG; Al Haj Baddar N; Demko ZP; Escrig C; Tabriziani H; Gauthier P; Billings PR; Amor AJ; Ferrer J; Campistol JM; Diekmann F
    Transplantation; 2022 Aug; 106(8):1690-1697. PubMed ID: 35289777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.
    Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM
    Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience.
    Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B
    Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.
    Wolf-Doty TK; Mannon RB; Poggio ED; Hinojosa RJ; Hiller D; Bromberg JS; Brennan DC
    Kidney360; 2021 Apr; 2(4):729-736. PubMed ID: 35373051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free DNA for the detection of kidney allograft rejection.
    Aubert O; Ursule-Dufait C; Brousse R; Gueguen J; Racapé M; Raynaud M; Van Loon E; Pagliazzi A; Huang E; Jordan SC; Chavin KD; Gupta G; Kumar D; Alhamad T; Anand S; Sanchez-Garcia J; Abdalla BA; Hogan J; Garro R; Dadhania DM; Jain P; Mandelbrot DA; Naesens M; Dandamudi R; Dharnidharka VR; Anglicheau D; Lefaucheur C; Loupy A
    Nat Med; 2024 Aug; 30(8):2320-2327. PubMed ID: 38824959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients.
    Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q
    Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving the surveillance and workup of heart transplant rejection: A real-world analysis of the Molecular Microscope Diagnostic System.
    Alam A; Van Zyl J; Paul Milligan G; Michelle McKean S; Patel R; Anne Hall S
    Am J Transplant; 2022 Oct; 22(10):2443-2450. PubMed ID: 35514138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation.
    Richmond ME; Zangwill SD; Kindel SJ; Deshpande SR; Schroder JN; Bichell DP; Knecht KR; Mahle WT; Wigger MA; Gaglianello NA; Pahl E; Simpson PM; Dasgupta M; North PE; Hidestrand M; Tomita-Mitchell A; Mitchell ME
    J Heart Lung Transplant; 2020 May; 39(5):454-463. PubMed ID: 31983667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators.
    Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA;
    Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.
    Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA
    Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients.
    Altuğ Y; Liang N; Ram R; Ravi H; Ahmed E; Brevnov M; Swenerton RK; Zimmermann B; Malhotra M; Demko ZP; Billings PR; Ryan A
    Transplantation; 2019 Dec; 103(12):2657-2665. PubMed ID: 30801536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
    Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
    Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD
    Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.
    Khush K; Hall S; Kao A; Raval N; Dhingra R; Shah P; Bellumkonda L; Ravichandran A; Van Bakel A; Uriel N; Patel S; Pinney S; DePasquale E; Baran DA; Pinney K; Oreschak K; Kobulnik J; Shen L; Teuteberg J
    J Heart Lung Transplant; 2024 Sep; 43(9):1409-1421. PubMed ID: 38759766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Donor-derived Cell-free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies.
    Gupta G; Moinuddin I; Kamal L; King AL; Winstead R; Demehin M; Kang L; Kimball P; Levy M; Bhati C; Massey HD; Kumar D; Halloran PF
    Transplantation; 2022 May; 106(5):1061-1070. PubMed ID: 34075006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection.
    Steggerda JA; Pizzo H; Garrison J; Zhang X; Haas M; Kim IK; Jordan SC; Puliyanda DP
    Pediatr Transplant; 2022 Jun; 26(4):e14258. PubMed ID: 35340104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.